<DOC>
	<DOCNO>NCT02744170</DOCNO>
	<brief_summary>Oxygen supplementation proven effective hypoxemic COPD patient increase oxygenation reduce dyspnea . In clinical practice three common oxygen delivery system use : continuous oxygen flow ( CF ) , demand oxygen delivery liquid oxygen ( DDL ) demand oxgen delivery portable oxygen concentrator ( DDC ) . The CF involve considerable wastage oxygen oxygen supply in- exhalation . Demand oxygen delivery save oxygen result comparable oxygen saturation rest COPD patient . However , unknown , oxygen supplementation via demand oxygen delivery also sufficient exercise hypoxemic COPD patient . In addition , consider low weight demand oxygen delivery system might enable patient high physical activity level mobility daily life . The effect These three oxygen delivery system shall investigate randomize , control cross-over Trial . Every patient perform Incremental Shuttle Walk Test three Endurance Shuttle Walk Tests three different oxygen supplementation ( via CF , DDL DDK ) randomize order .</brief_summary>
	<brief_title>Effects Supplemental Oxygen Delivery Via Demand Versus Continuous Flow Hypoxemic COPD Patients</brief_title>
	<detailed_description>The Principal Investigator inform patient procedure , content measurement study . It obligatory patient participate study give write informed consent . Following initial incremental shuttle walk test ( ISWT ) order determine individual maximum capacity , patient perform three endurance shuttle walk test ( ESWT ) 85 % maximal pace . In randomized order , patient complete one ESWT CF , one DDL ( liquid oxygen ) one DDC ( portable oxygen concentrator ) . The time three ESWTs 24 hour order give enough time regeneration . All patient use oxygen device ( CF : Companion 1000 ( CE 0050 ) , Chart Industries , Inc. Garfield Heights , Ohio , USA ; DD [ liquid oxygen ] : Caire Spirit 300 ( CE 0029 ) , Chart Industries , Inc. Garfield Heights , Ohio , USA ) , DD [ portable concentrator ] : Inogen G2 , California , USA ) carry oxygen device backpack . Continuous oxygen flow liter per minute compare level demand delivery ( e.g . : 2 l/min CF compare DD level 2 ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>COPD patient ( GOLD stage III IV ) hypoxemia rest exercise ( paO2 &lt; 60mmHg ) Participation inpatient pulmonary rehabilitation program ( Sch√∂n Klinik BGL ) Written inform consent General exclusion criterion exercise test , e.g . acute coronary syndrome , acute myo pericarditis , acute lung embolism , pulmonary infarction , acute uncontrolled heart insufficiency Signs acute exacerbation Any orthopedic neurological disability prevent patient walking</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Incremental Shuttle Walk Test</keyword>
	<keyword>Endurance Shuttle Walk Test</keyword>
	<keyword>oxygen therapy</keyword>
</DOC>